Lifeward (LFWD) Notes Payables (2025)

Lifeward's (LFWD) quarterly Notes Payables came in at $2.8 million in Q4 2025.

Lifeward (LFWD) Notes Payables (2025) Analysis & Trends

Lifeward has disclosed Notes Payables across 1 years of filings, most recently posting $2.8 million for Q4 2025.

  • Notes Payables for Q4 2025 came in at $2.8 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $2.8 million (changed N/A YoY), and the FY2025 annual result was $2.8 million, changed N/A from the prior year.
  • Notes Payables came in at $2.8 million for Q4 2025 at Lifeward.
  • In the past five years, Notes Payables ranged from a high of $2.8 million in Q4 2025 to a low of $2.8 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Lifeward 11.14 Mn -263,371.13 1.34 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.80 Mn